Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €5.58 EUR
Change Today -0.069 / -1.22%
Volume 0.0
6DW On Other Exchanges
Symbol
Exchange
Tokyo
Berlin
As of 8:02 AM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

d.western therapeutics insti (6DW) Snapshot

Open
€5.27
Previous Close
€5.65
Day High
€5.58
Day Low
€5.21
52 Week High
08/18/14 - €24.90
52 Week Low
07/10/15 - €5.11
Market Cap
127.2M
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
22.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for D.WESTERN THERAPEUTICS INSTI (6DW)

Related News

No related news articles were found.

d.western therapeutics insti (6DW) Related Businessweek News

No Related Businessweek News Found

d.western therapeutics insti (6DW) Details

D. Western Therapeutics Institute, Inc., a biotechnology company, discovers and develops new drugs to serve patients worldwide. The company offers GLANATEC, an ophthalmic solution for the treatment of glaucoma/ocular hypertension. It also develops K-134, an anti-platelet that has completed phase IIb trial for the treatment of arteriosclerosis obliterans; and H-1129, an anti-glaucoma drug, which is in non-clinical studies for the treatment of glaucoma. In addition, the company’s discovery stage products include anti-glaucoma, central nervous system, cardiovascular system, and respiratory system drugs, as well as ophthalmology and related area products. The company was founded in 1999 and is headquartered in Nagoya, Japan.

13 Employees
Last Reported Date: 03/24/15
Founded in 1999

d.western therapeutics insti (6DW) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

d.western therapeutics insti (6DW) Key Developments

D.Western Therapeutics Institute, Inc. to Report Q1, 2015 Results on May 14, 2015

D.Western Therapeutics Institute, Inc. announced that they will report Q1, 2015 results on May 14, 2015

D.Western Therapeutics Institute, Inc., Annual General Meeting, Mar 24, 2015

D.Western Therapeutics Institute, Inc., Annual General Meeting, Mar 24, 2015.

D.Western Therapeutics Institute, Inc., 2014 Earnings Call, Feb 27, 2015

D.Western Therapeutics Institute, Inc., 2014 Earnings Call, Feb 27, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
6DW:GR €5.58 EUR -0.069

6DW Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 6DW.
View Industry Companies
 

Industry Analysis

6DW

Industry Average

Valuation 6DW Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 186.5x
Price/Book 8.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 165.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact D.WESTERN THERAPEUTICS INSTI, please visit www.dwti.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.